Latest Low-density lipoprotein Stories
- Primary efficacy endpoints met in all nine new trials of investigational PCSK9 inhibitor - PARIS and TARRYTOWN, N.Y., July 30, 2014 /PRNewswire/ -- Sanofi (EURONEXT: SAN and NYSE: SNY) and
Diet Doc’s new cholesterol diet plans focus on helping people in any part of the country lose weight fast and improve their health by reducing bad cholesterol levels Dallas,
Agents That Reduce the Incidence of Cardiovascular Adverse Events Remain a Key Unmet Need for Both Physicians and Payers, According to Findings from Decision Resources Group BURLINGTON, Mass.,
CARLSBAD, Calif., July 17, 2014 /PRNewswire/ -- Isis Pharmaceuticals, Inc.
INDIANAPOLIS, July 9, 2014 /PRNewswire/ -- Chek Diagnostics, the U.S.-based manufacturer of both the CardioChek® brand and the A1CNow® family of point-of-care diagnostic products, announced today
Two new studies presented today at the European League Against Rheumatism Annual Congress (EULAR 2014) have helped clarify the relationship between the dietary intake of monounsaturated fatty acids and cholesterol with disease activity in rheumatoid arthritis (RA) and osteoarthritis (OA) respectively.
As hormone levels change during the transition to menopause, the quality of a woman’s cholesterol carriers degrades, leaving her at greater risk for heart disease, researchers at the University
The lives of millions of Americans are potentially at risk. NEW YORK, June 25, 2014 /PRNewswire-USNewswire/ -- The EPA Drug Initiative (EPADI) urges the FDA to thoughtfully consider
Achievement of LDL Particle Targets Associated with More Aggressive Lipid-lowering Therapy and Better Clinical Outcomes Compared to Patients Managed to LDL Cholesterol Targets RALEIGH,
- A poem in which the author retracts something said in an earlier poem.